Hepatitis B vs. HIV: Key Similarities and Differences

Both hepatitis B virus (HBV) and human immunodeficiency virus (HIV) are serious bloodborne pathogens, but they differ in transmission, target organs, treatment, and prevention.

Comparison Table

FeatureHepatitis B (HBV)HIV
Primary TargetLiver cells (hepatocytes)Immune cells (CD4+ T lymphocytes)
TransmissionBlood, sexual contact, perinatal, shared needles; highly infectious (100x more than HIV via needlestick)Blood, sexual contact, perinatal, shared needles; less efficient per exposure
Chronic Infection Rate~5–10% of adults; higher in infants/childrenNearly 100% without treatment
Long-Term ComplicationsCirrhosis, hepatocellular carcinoma, liver failureAIDS, opportunistic infections, malignancies, cardiovascular/renal disease
TreatmentAntivirals (entecavir, tenofovir) suppress replication; functional cure (HBsAg loss) rareAntiretroviral therapy (ART) suppresses virus; undetectable = untransmittable (U=U)
CureNo complete cure; functional cure possibleNo cure; two cases of sterilizing cure via stem cell transplant
VaccineHighly effective vaccine available (3-dose series); universal infant immunizationNo licensed vaccine; research ongoing (pre-exposure prophylaxis/PrEP is preventive)
Post-Exposure ProphylaxisHBIG + vaccine seriesART regimen within 72 hours

Key Takeaways

  • HBV is more easily transmitted via blood exposure; HIV is more fragile outside the body.
  • HBV has a preventive vaccine; HIV does not.
  • Both can be managed long-term with medication, but adherence is critical for HIV.
  • Coinfection (HBV/HIV) occurs and requires coordinated care.

Viral Infections - Related Articles